Yale researchers enroll first patient in study of heart-preserving molecule
(Medical Xpress) -- A 69-year-old man became the first patient enrolled and treated in an ongoing study at Yale School of Medicine of BB3, a molecule that promises to preserve heart muscle, promote healing and improve clinical ...
Jul 24, 2012
0
0